Un hallazgo en la Antártida podría cambiar el mercado energético Ivar AI

Ambcrypto.com

Crypto market cap surpasses France, UK GDPs – India, Japan next

CNN

Google says it has cracked a quantum computing challenge with new chip | CNN Business

Storagereview.com

Google's Willow Chip Reaches Computational Capacity Milestone

BeInCrypto

La capitalización realizada de Ethereum registra máximo histórico y sugiere problemas para los bajistas de ETH

Forbes

AI For Climate Change: A Range Of Ideas On Applications

BusinessLine

India may attract share of $36-trillion principal investor capital: BCG

CNBC

Stock market today: Live updates

Milenio

Google invierte 800 millones en Intersect Power

BeInCrypto

Los ETF spot de Bitcoin tienen entradas diarias de $439 millones pese a la caída del mercado

CNA

China sends largest naval fleet in decades to region, threat level severe, Taiwan says

GlobeNewswire

The Kingdom Of Saudi Arabia Artificial Intelligence (Ai) Market Is Expected To Reach Revenue Of USD 61,854.4 Mn By 2033, At 46.6% Cagr: Dimension Market Research.

Xataka.com.co

Estados Unidos y Colombia lanzan alianza de seguridad para combatir el crimen organizado con drones

ABC News

Five years since its inception, a US development agency competes with China on global projects

newsBTC

Ethereum Price Breakout: Charting The Uncertain Part Of ETH To $18,000

The Irish Times

Israel moves tanks into Golan Heights demilitarised zone and strikes ‘strategic targets’ in Syria

GlobeNewswire

The Rise of Social Media Management Market: A $ 51.8 billion Industry Dominated by IBM (US) and Cisco (US) | MarketsandMarkets™

VOA News

VOA Mandarin: China beefing up naval deployment surrounding Taiwan

GlobeNewswire

TECVAYLI®▼ (teclistamab) demonstrates potential as frontline combination therapy for patients with newly diagnosed multiple myeloma

$Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma$

GlobeNewswire

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

$Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients$

GlobeNewswire

Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients